MedTech Mindset

In this episode, Rightley McConnell, VP of Operations at Precision Systems, Inc., covers how to maintain quality and speed when developing medical device software. Rightley and Dan discuss:Challenges to device software development for complex systemsUse of AGILE methodology in a regulated environmentApplicable standards including 21 CFR 820, ISO 13485, ISO 14971How quality can remain central at each development phaseAnd more. Rightley can be reached at rmcconnell@psi-software.com.

In this episode, Rightley McConnell, VP of Operations at Precision Systems, Inc., covers how to maintain quality and speed when developing medical device software. Rightley and Dan discuss:Challenges to device software development for complex systemsUse of AGILE methodology in a regulated environmentApplicable standards including 21 CFR 820, ISO 13485, ISO 14971How quality can remain central at each development phaseAnd more. Rightley can be reached at rmcconnell@psi-software.com.

In this episode, Seth Goldenberg, VP of Vault Medical Device & Diagnostics at Veeva Systems, cover data flow throughout the product lifecyle and how advanced data management can speed devices along the path to market. Seth and Dan discuss:How data management and access impact the product lifecycleWhat the device industry can learn from pharma's data practicesHow EU MDR is changing the data landscapeWhen in a device company's growth does a cloud system start to make sense?

In this episode, Seth Goldenberg, VP of Vault Medical Device & Diagnostics at Veeva Systems, cover data flow throughout the product lifecyle and how advanced data management can speed devices along the path to market. Seth and Dan discuss:How data management and access impact the product lifecycleWhat the device industry can learn from pharma's data practicesHow EU MDR is changing the data landscapeWhen in a device company's growth does a cloud system start to make sense?

In Part II of this two-part episode, Adam Dakin, Managing Director of Dreamit Health, covers funding trends in medtech and how to pitch to institutional investors. Adam and Dan discuss:Medtech funding trends and how they've changed in recent yearsInvestor perspectives on medtech vs. digital healthHow to build value to make your startup attractiveTips for success at the pitch table

In Part II of this two-part episode, Adam Dakin, Managing Director of Dreamit Health, covers funding trends in medtech and how to pitch to institutional investors. Adam and Dan discuss:Medtech funding trends and how they've changed in recent yearsInvestor perspectives on medtech vs. digital healthHow to build value to make your startup attractiveTips for success at the pitch table

In this episode, Adam Dakin, Managing Director of Dreamit Health, covers funding trends in medtech and how to pitch to institutional investors. (Part I of II)Adam and Dan discuss:Medtech funding trends and how they've changed in recent yearsInvestor perspectives on medtech vs. digital healthHow to build value to make your startup attractiveTips for success at the pitch table

In this episode, Adam Dakin, Managing Director of Dreamit Health, covers funding trends in medtech and how to pitch to institutional investors. (Part I of II)Adam and Dan discuss:Medtech funding trends and how they've changed in recent yearsInvestor perspectives on medtech vs. digital healthHow to build value to make your startup attractiveTips for success at the pitch table

In this episode, Gregory Bernabeo, Patent Attorney and Partner at FisherBroyles, covers intellectual property ground rules and special topics in the medtech space. Greg and Dan discuss:Why a patent isn't what (exactly) what you thought it wasIs my medtech innovation patentable?Are patents valuable if I can't afford to litigate?Can medtech innovators protect their IP rights and publish their research?What's important when selecting a patent attorney for my medtech project?

In this episode, Gregory Bernabeo, Patent Attorney and Partner at FisherBroyles, covers intellectual property ground rules and special topics in the medtech space. Greg and Dan discuss:Why a patent isn't what (exactly) what you thought it wasIs my medtech innovation patentable?Are patents valuable if I can't afford to litigate?Can medtech innovators protect their IP rights and publish their research?What's important when selecting a patent attorney for my medtech project?

In this episode, Matt Maltese, Executive Director of the PA Pediatric Medical Device Consortium and Dan Henrich discuss:Current barrier to pediatric device innovationHow pediatric specialists operate without pediatric devicesRisk/Benefit rationale for small patient populationsCurrent industry and FDA initiatives to bring more devices to market for kids

In this episode, Matt Maltese, Executive Director of the PA Pediatric Medical Device Consortium and Dan Henrich discuss:Current barrier to pediatric device innovationHow pediatric specialists operate without pediatric devicesRisk/Benefit rationale for small patient populationsCurrent industry and FDA initiatives to bring more devices to market for kids

In this episode, regulatory expert Monica Ferrante, VP of Regulatory and Quality at Aspire Bariatrics, talks regulatory strategy and approvals for new medical devices coming to market.Monica and Dan discuss:FDA risk classifications and how to steer down various regulatory pathwaysHow FDA is changing in recent yearsTrends in regulation--are medical devices under-regulated by FDA?Formal vs. informal pre-submission meetings with FDAHow to go about finding trustworthy regulatory support

In this episode, regulatory expert Monica Ferrante, VP of Regulatory and Quality at Aspire Bariatrics, talks regulatory strategy and approvals for new medical devices coming to market.Monica and Dan discuss:FDA risk classifications and how to steer down various regulatory pathwaysHow FDA is changing in recent yearsTrends in regulation--are medical devices under-regulated by FDA?Formal vs. informal pre-submission meetings with FDAHow to go about finding trustworthy regulatory support

In this episode, branding expert Bill Gullan, President of Finch Brands, speaks with Smithwise Marketing Director Daniel Henrich about what branding is and why's it's critical in the world of medtech ventures. Bill and Dan discuss:What branding is, and what it's notHow company identity and go-to-market strategy are reflected in a brandWhen is the right time to worry about branding? Developing market and buyer insightsNaming your product and company

In this episode, branding expert Bill Gullan, President of Finch Brands, speaks with Smithwise Marketing Director Daniel Henrich about what branding is and why's it's critical in the world of medtech ventures. Bill and Dan discuss:What branding is, and what it's notHow company identity and go-to-market strategy are reflected in a brandWhen is the right time to worry about branding? Developing market and buyer insightsNaming your product and company

On this episode, we sit down with Stephen and Anna John, a brother-sister team of medical device developers, working to bring life-saving respiratory therapy to the developing world. Their device, NeoVent, is a low-cost, mechanical solution to deliver two levels of air pressure to infants in respiratory distress without the need for continuous electric power.Stephen and Anna grew up in rural Nepal, where their family worked to meet the medical needs of an undeserved population. Their father, Sunil, is a pediatric cardiologist and continues to split his time between practicing in Kalamazoo, Michigan and Nepal. Sunil is serving as a clinical advisor in the development of NeoVent. They're working to bring NeoVent to market through their company, AIM Tech. You can contact them through their website or by sending an email to stephen.john@aimtechhealth.com."Every year, over one million infants die of severe respiratory illnesses, making it one of the leading causes of under five mortality in the world. 99% of those are in low to middle income countries, which shows you that there are good treatments for these conditions, but they're not reaching most of the world." -Stephen John, CEO, AIM Tech

On this episode, we sit down with Stephen and Anna John, a brother-sister team of medical device developers, working to bring life-saving respiratory therapy to the developing world. Their device, NeoVent, is a low-cost, mechanical solution to deliver two levels of air pressure to infants in respiratory distress without the need for continuous electric power.Stephen and Anna grew up in rural Nepal, where their family worked to meet the medical needs of an undeserved population. Their father, Sunil, is a pediatric cardiologist and continues to split his time between practicing in Kalamazoo, Michigan and Nepal. Sunil is serving as a clinical advisor in the development of NeoVent. They're working to bring NeoVent to market through their company, AIM Tech. You can contact them through their website or by sending an email to stephen.john@aimtechhealth.com."Every year, over one million infants die of severe respiratory illnesses, making it one of the leading causes of under five mortality in the world. 99% of those are in low to middle income countries, which shows you that there are good treatments for these conditions, but they're not reaching most of the world." -Stephen John, CEO, AIM Tech

In this episode, Joe Popowicz, founder of Emergent Clinical Consulting, sits down with Smithwise President Eric Sugalski to talk about clinical evidence strategies surrounding new medtech. They cover pre/postmarket data needs, regulatory pathways, Value Analysis Committees, Significant Risk vs. Nonsignificant Risk, Institutional Review Boards, and more. See more and find contact info for Joe on the Smithwise.com blog.

In this episode, Joe Popowicz, founder of Emergent Clinical Consulting, sits down with Smithwise President Eric Sugalski to talk about clinical evidence strategies surrounding new medtech. They cover pre/postmarket data needs, regulatory pathways, Value Analysis Committees, Significant Risk vs. Nonsignificant Risk, Institutional Review Boards, and more. See more and find contact info for Joe on the Smithwise.com blog.

We're joined this episode by Wamis Singhatat, VP of Product Development and CTO of Active Protective, a medtech company working to bring a really cool new piece of technology to market. Their product is a smart belt that can detect a fall in progress and deploy airbags to cushion the hips of the wearer. You can see a video of the deployment in action on the Smithwise blog. Wamis sat down with Smithwise President Eric Sugalski to discuss their strategies for bringing this product to market.

We're joined this episode by Wamis Singhatat, VP of Product Development and CTO of Active Protective, a medtech company working to bring a really cool new piece of technology to market. Their product is a smart belt that can detect a fall in progress and deploy airbags to cushion the hips of the wearer. You can see a video of the deployment in action on the Smithwise blog. Wamis sat down with Smithwise President Eric Sugalski to discuss their strategies for bringing this product to market.

Welcome to Medtech Mindset, a production of Smithwise. This episode is a great way to tell if this podcast is for you.Eric Sugalski and Dan Henrich sit down to discuss the big picture of bringing a new piece of medical technology to market. We touch on product development and designregulatory pathwaysclinical evidencego-to-market strategyintellectual propertyother themes. In coming episodes, we'll explore these topics in more detail with guests who are experts in these areas and guests who have recently been through the process.

Welcome to Medtech Mindset, a production of Smithwise. This episode is a great way to tell if this podcast is for you.Eric Sugalski and Dan Henrich sit down to discuss the big picture of bringing a new piece of medical technology to market. We touch on product development and designregulatory pathwaysclinical evidencego-to-market strategyintellectual propertyother themes. In coming episodes, we'll explore these topics in more detail with guests who are experts in these areas and guests who have recently been through the process.